BCM
JNCE

BlueCrest Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

BlueCrest Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,488
Closed -$81K – 1515
2018
Q3 		$81K Buy
+12,488
New +$81K ﹤0.01% 1391